Evidence map›Paper›PMID 40804749›Full record

ArticleBMC rheumatology2025

High ischemic deficit in computed tomography perfusion is a risk factor for cerebral vascular ischemic events in Takayasu arteritis: a prospective observational study.

Rongyi Chen, Ying Sun, Ying Liu, Jing Ding, Lindi Jiang

Registry-linked trialAbstract read
In one paragraph

Article in BMC rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03893136 (The Cohort Study of East Chinese Takayasu's Arteritis), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03893136 unknown statusnot on this map

The Cohort Study of East Chinese Takayasu's Arteritis (ECTA-cohort Study)

TypeobservationalSponsorShanghai Zhongshan HospitalRan2016 to 2026Enrolled1,000ConditionsTakayasu Arteritis, Mechanisms, Defense, Pregnancy Related, Treatment RefusalArmsTocilizumab, Leflunomide
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rongyi ChenDepartment of Rheumatology, Zhongshan Hospital Fudan University, No.180, Fenglin Road, Xuhui District, Shanghai, 200032, China.
Ying SunDepartment of Rheumatology, Zhongshan Hospital Fudan University, No.180, Fenglin Road, Xuhui District, Shanghai, 200032, China.
Ying LiuDepartment of Neurology, Zhongshan Hospital Fudan University, Shanghai, 200032, China.
Jing DingDepartment of Neurology, Zhongshan Hospital Fudan University, Shanghai, 200032, China.
Lindi JiangDepartment of Rheumatology, Zhongshan Hospital Fudan University, No.180, Fenglin Road, Xuhui District, Shanghai, 200032, China. zsh-rheum@hotmail.com.

Funding

China Postdoctoral Science Foundation 2022M720777
6 · The paper itself

Abstract

backgroundPatients suffering from Takayasu arteritis (TA) with stenosis or occlusion of supra-aortic trunks carry a high risk of cerebral vascular ischemic events (CVIEs). We explored the relationship between cerebral blood perfusion and CVIEs in TA.

methodsPatients with involvement of supra-aortic trunks undergoing computed tomographic perfusion (CTP) were enrolled. The primary endpoint was CVIEs. The secondary endpoint was a poor outcome (modified Rankin scale, mRS > 3). The relationship between CTP parameters, ischemic deficit (time to maximum, Tmax >6 s) and ischemic core (cerebral blood flow, CBF < 30%), CVIEs, and a poor outcome during follow-up was analyzed with Spearman correlation, Cox regression, cluster analysis, and Kaplan–Meier curves.

resultsEighty-one patients were enrolled. The median volume of the ischemic deficit was 2.5 (IQR 0–34.1) mL. The ischemic deficit was related to a previous ischemic stroke, abnormal vision, and vertebral-artery stenosis (all p < 0.05). During a median follow-up of 16.0 (IQR 3.0–29.0) months, 16 cases suffered CVIEs, including ischemic stroke (11 cases, 68.8%), ablepsia (six, 37.5%), death (three, 18.8%), other worsening cerebral ischemic symptoms (three, 18.8%). The CVIEs were independently associated with the ischemic deficit (hazard ratio, HR = 15.66[4.09–59.96], p < 0.001), hemoglobin (HR = 0.96[0.93–0.99], p = 0.003), and tocilizumab use (HR = 5.71[1.63–20.00], p < 0.001). The AUC of the ischemic deficit to predict CVIEs was 0.79 (95%CI = 62.07–95.62) at 1 year and 0.81 (95%CI = 0.65–0.96) at 3 years, respectively. Furthermore, patients could be clustered into three groups. Cluster 1 (inflammation type) and cluster 2 (non-inflammation type) shared a similar risk for CVIEs. Cluster 3 (inflammation with low-perfusion type) carried the highest risk for a CVIE (HR 35.21[4.63–267.58], p < 0.001) compared with cluster 1. Kaplan–Meier curves revealed that patients with high ischemic deficit or belonging to cluster 3 carried a higher risk of CVIEs or a poor outcome.

conclusionsThe high ischemic deficit is a risk factor for CVIEs in TA with involvement of supra-aortic trunks. Patients with inflammation and high ischemic deficit carry a high risk of suffering CVIEs and a poor outcome during follow-up. RETROSPECTIVELY REGISTERED.

trial registrationClinicalTrials.gov NCT03893136 REGISTRATION DATE: 2019-03-25.

Indexed as

Cerebral vascular ischemic eventComplement 3CT perfusionIschemic deficitIschemic strokeTakayasu arteritis

Identifiers

PMID40804749
PMCPMC12344923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.